756 related articles for article (PubMed ID: 28816346)
1. Homocysteine-lowering interventions for preventing cardiovascular events.
Martí-Carvajal AJ; Solà I; Lathyris D; Dayer M
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD006612. PubMed ID: 28816346
[TBL] [Abstract][Full Text] [Related]
2. Homocysteine-lowering interventions for preventing cardiovascular events.
Martí-Carvajal AJ; Solà I; Lathyris D
Cochrane Database Syst Rev; 2015 Jan; 1():CD006612. PubMed ID: 25590290
[TBL] [Abstract][Full Text] [Related]
3. Homocysteine-lowering interventions for preventing cardiovascular events.
Martí-Carvajal AJ; Solà I; Lathyris D; Karakitsiou DE; Simancas-Racines D
Cochrane Database Syst Rev; 2013 Jan; (1):CD006612. PubMed ID: 23440809
[TBL] [Abstract][Full Text] [Related]
4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
5. Homocysteine lowering interventions for preventing cardiovascular events.
Martí-Carvajal AJ; Solà I; Lathyris D; Salanti G
Cochrane Database Syst Rev; 2009 Oct; (4):CD006612. PubMed ID: 19821378
[TBL] [Abstract][Full Text] [Related]
6. Interventions for lowering plasma homocysteine levels in dialysis patients.
Nigwekar SU; Kang A; Zoungas S; Cass A; Gallagher MP; Kulshrestha S; Navaneethan SD; Perkovic V; Strippoli GF; Jardine MJ
Cochrane Database Syst Rev; 2016 May; 2016(5):CD004683. PubMed ID: 27243372
[TBL] [Abstract][Full Text] [Related]
7. Antibiotics for secondary prevention of coronary heart disease.
Sethi NJ; Safi S; Korang SK; Hróbjartsson A; Skoog M; Gluud C; Jakobsen JC
Cochrane Database Syst Rev; 2021 Feb; 2(2):CD003610. PubMed ID: 33704780
[TBL] [Abstract][Full Text] [Related]
8. Beta-blockers for suspected or diagnosed acute myocardial infarction.
Safi S; Sethi NJ; Nielsen EE; Feinberg J; Jakobsen JC; Gluud C
Cochrane Database Syst Rev; 2019 Dec; 12(12):CD012484. PubMed ID: 31845756
[TBL] [Abstract][Full Text] [Related]
9. Chelation therapy for atherosclerotic cardiovascular disease.
Villarruz-Sulit MV; Forster R; Dans AL; Tan FN; Sulit DV
Cochrane Database Syst Rev; 2020 May; 5(5):CD002785. PubMed ID: 32367513
[TBL] [Abstract][Full Text] [Related]
10. Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD).
Ruospo M; Palmer SC; Natale P; Craig JC; Vecchio M; Elder GJ; Strippoli GF
Cochrane Database Syst Rev; 2018 Aug; 8(8):CD006023. PubMed ID: 30132304
[TBL] [Abstract][Full Text] [Related]
11. Vitamin B and its derivatives for diabetic kidney disease.
Raval AD; Thakker D; Rangoonwala AN; Gor D; Walia R
Cochrane Database Syst Rev; 2015 Jan; 1():CD009403. PubMed ID: 25579852
[TBL] [Abstract][Full Text] [Related]
12. Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial.
Albert CM; Cook NR; Gaziano JM; Zaharris E; MacFadyen J; Danielson E; Buring JE; Manson JE
JAMA; 2008 May; 299(17):2027-36. PubMed ID: 18460663
[TBL] [Abstract][Full Text] [Related]
13. Ezetimibe for the prevention of cardiovascular disease and all-cause mortality events.
Zhan S; Tang M; Liu F; Xia P; Shu M; Wu X
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD012502. PubMed ID: 30480766
[TBL] [Abstract][Full Text] [Related]
14. Fixed-dose combination therapy for the prevention of atherosclerotic cardiovascular diseases.
Bahiru E; de Cates AN; Farr MR; Jarvis MC; Palla M; Rees K; Ebrahim S; Huffman MD
Cochrane Database Syst Rev; 2017 Mar; 3(3):CD009868. PubMed ID: 28263370
[TBL] [Abstract][Full Text] [Related]
15. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Sbidian E; Chaimani A; Afach S; Doney L; Dressler C; Hua C; Mazaud C; Phan C; Hughes C; Riddle D; Naldi L; Garcia-Doval I; Le Cleach L
Cochrane Database Syst Rev; 2020 Jan; 1(1):CD011535. PubMed ID: 31917873
[TBL] [Abstract][Full Text] [Related]
16. Prophylactic lidocaine for myocardial infarction.
Martí-Carvajal AJ; Simancas-Racines D; Anand V; Bangdiwala S
Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD008553. PubMed ID: 26295202
[TBL] [Abstract][Full Text] [Related]
17. Fixed-dose combination therapy for the prevention of cardiovascular disease.
de Cates AN; Farr MR; Wright N; Jarvis MC; Rees K; Ebrahim S; Huffman MD
Cochrane Database Syst Rev; 2014 Apr; 4(4):CD009868. PubMed ID: 24737108
[TBL] [Abstract][Full Text] [Related]
18. Beta-blockers in patients without heart failure after myocardial infarction.
Safi S; Sethi NJ; Korang SK; Nielsen EE; Feinberg J; Gluud C; Jakobsen JC
Cochrane Database Syst Rev; 2021 Nov; 11(11):CD012565. PubMed ID: 34739733
[TBL] [Abstract][Full Text] [Related]
19. Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease.
Abdelhamid AS; Brown TJ; Brainard JS; Biswas P; Thorpe GC; Moore HJ; Deane KH; Summerbell CD; Worthington HV; Song F; Hooper L
Cochrane Database Syst Rev; 2020 Feb; 3(3):CD003177. PubMed ID: 32114706
[TBL] [Abstract][Full Text] [Related]
20. Peroxisome proliferator-activated receptor gamma agonists for preventing recurrent stroke and other vascular events in people with stroke or transient ischaemic attack.
Liu J; Wang LN
Cochrane Database Syst Rev; 2017 Dec; 12(12):CD010693. PubMed ID: 29197071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
